Literature DB >> 10323210

Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.

E R Brandt1, W A Hayman, B Currie, J Carapetis, D C Jackson, K A Do, M F Good.   

Abstract

The mucosa is one of the initial sites of group A streptococcal (GAS) infection and salivary IgA (sIgA) is thought to be critical to immunity. However, the target epitopes of sIgA and the function of sIgA in GAS immunity, in particular the role of accessory cells and complement, is largely unknown. We studied the aquisition and the function of sIgA specific for a conserved region epitope, p145 (sequence: LRRDLDASREAKKQVEKALE) of the M protein. Peptide 145-specific sIgA is highly prevalent within an Aboriginal population living in an area endemic for GAS and acquisition of p145-specific sIgA increases with age, consistent with a role for such antibodies in immunity to GAS. Human sIgA and IgG specific for p145 were affinity purified and shown to opsonize M5 GAS in vitro. Opsonization could be specifically inhibited by the addition of free p145 to the antibodies during assay. Opsonization of GAS was totally dependent on the presence of both complement and polymorphonuclear leukocytes, and, moreover, affinity-purified p145-specific sIgA was shown to fix complement in the presence of M5 GAS. These data show that mucosal IgA to this conserved region peptide within the M protein has an important role in human immunity against GAS and may be useful in a broad-based cross-protective anti-streptococcal vaccine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323210     DOI: 10.1093/intimm/11.4.569

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8.

Authors:  Patricia Therese Campbell; Hannah Frost; Pierre R Smeesters; Joseph Kado; Michael F Good; Michael Batzloff; Nicholas Geard; Jodie McVernon; Andrew Steer
Journal:  Vaccine       Date:  2018-11-03       Impact factor: 3.641

Review 2.  Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease.

Authors:  Michael R Batzloff; Manisha Pandey; Colleen Olive; Michael F Good
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Rheumatic fever.

Authors:  E Rullan; L H Sigal
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

4.  Vaccine strategies to prevent rheumatic fever.

Authors:  E R Brandt; M F Good
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

5.  Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model.

Authors:  J McArthur; E Medina; A Mueller; J Chin; B J Currie; K S Sriprakash; S R Talay; G S Chhatwal; M J Walker
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

6.  Identification of B- and T-cell epitopes within the fibronectin-binding domain of the SfbI protein of Streptococcus pyogenes.

Authors:  Kai Schulze; Eva Medina; Gursharan S Chhatwal; Carlos A Guzmán
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  Novel platform technology for modular mucosal vaccine that protects against streptococcus.

Authors:  Mehfuz Zaman; Victoria Ozberk; Emma L Langshaw; Virginia McPhun; Jessica L Powell; Zachary N Phillips; Mei Fong Ho; Ainslie Calcutt; Michael R Batzloff; Istvan Toth; Geoffrey R Hill; Manisha Pandey; Michael F Good
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

8.  Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super-infection.

Authors:  Mehfuz Zaman; Victor C Huber; Dustin L Heiden; Katerina N DeHaan; Sanyogita Chandra; Demi Erickson; Victoria Ozberk; Manisha Pandey; Benjamin Bailly; Gael Martin; Emma L Langshaw; Ali Zaid; Mark von Itzstein; Michael F Good
Journal:  Clin Transl Immunology       Date:  2021-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.